Literature DB >> 7251921

Spastic dysphonia: a continuum disorder.

M P Cannito, J P Johnson.   

Abstract

Recently, two types of spastic dysphonia, adductor and abductor, have been proposed. The literature suggests that patients may be categorized as having one form of the disorder or the other. The present study presents case history and spectrographic data on a patient who evidences vocal characteristics of both disorder types. It is suggested that spastic dysphonia is a disorder involving a harshness-breathiness continuum and is not amenable to strict, binary categorization.

Entities:  

Mesh:

Year:  1981        PMID: 7251921     DOI: 10.1016/0021-9924(81)90037-x

Source DB:  PubMed          Journal:  J Commun Disord        ISSN: 0021-9924            Impact factor:   2.288


  6 in total

1.  Exploration on the underlying mechanism of female predominance in spasmodic dysphonia: an anatomical study of nodose ganglion in rats.

Authors:  Zengrui Xu; Ge Li; Xin Feng
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-09-22

Review 2.  Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.

Authors:  Andrew Blitzer; Mitchell F Brin; Kristina Simonyan; Laurie J Ozelius; Steven J Frucht
Journal:  Laryngoscope       Date:  2017-12-08       Impact factor: 3.325

Review 3.  Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs.

Authors:  C R Watts; D D Truong; C Nye
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

4.  Differentiating between adductor and abductor spasmodic dysphonia using airflow interruption.

Authors:  Matthew R Hoffman; Jack J Jiang; Adam L Rieves; Kelsey A B McElveen; Charles N Ford
Journal:  Laryngoscope       Date:  2009-09       Impact factor: 3.325

Review 5.  Chemodenervation of the Larynx.

Authors:  Rachel Kaye; Andrew Blitzer
Journal:  Toxins (Basel)       Date:  2017-11-02       Impact factor: 4.546

Review 6.  Botulinum toxin injections for the treatment of spasmodic dysphonia.

Authors:  C C W Watts; R Whurr; C Nye
Journal:  Cochrane Database Syst Rev       Date:  2004
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.